A Randomized, Controlled, Open-label Clinical Trial of Adjuvant Intensive Therapy for HR+/ HER2-SNF4 Early Breast Cancer

Clinical trial NCT05889871 · UNKNOWN

Trial details

NCT number: NCT05889871
Sponsor: Fudan University
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

HR+/HER2-breast Cancer

Start date: 2023-06-01
Primary completion: 2026-06-01
Enrollment: 916

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.